Labador, Baby Boy .
HRN: 21-26-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/15/2022
05/21/2022
IV
14mg
OD
PSNB Secondary To Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes